GG 623 GG 623 (Terazosin Hydrochloride 5 mg)

Pill with imprint GG 623 GG 623 is Pink, Capsule-shape and has been identified as Terazosin Hydrochloride 5 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 623 GG 623

Terazosin hydrochloride 5 mg GG 623 GG 623

Terazosin Hydrochloride

Imprint: GG 623 GG 623
Strength: 5 mg
Color: Pink
Size: 16.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Antiadrenergic agents, peripherally acting
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Sandoz Pharmaceuticals Inc.
Inactive Ingredients: corn starch, crospovidone, D&C Yellow No. 10, D&C Red No. 28, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, gelatin, lactose monohydrate, magnesium stearate, microcrystalline cellulose, shellac, propylene glycol, ferrosoferric oxide, titanium dioxide
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00781-2053 (Discontinued)	Sandoz Inc.
00904-6128 (Discontinued)	Major Pharmaceuticals
54569-4875	A-S Medication Solutions, LLC (repackager)
54868-4248 (Discontinued)	Physicians Total Care Inc. (repackager)
67544-0084	Prepak Systems Inc. (repackager)